Eleven and two thirds years' survival after canine orthotopic liver transplantation by Starzl, TE et al.
f, ! 
-. 
, 
, ~ ~ . 
168 TRANSPLANTATION Vol. 23, No.2 
explanation for the blocking activity observed 
in some patients. The cytotoxicity induced by 
normal effectors was not affected in our assay 
by the addition of several sera containing 
more than 200 mg of urea per 100 ml. There is 
experimental evidence that inhibition of 
ADCC can be produced by immune complexes 
(6,12,13) and by antibodies against lympho-
cyte surface antigens (9) via a common mech-
anism, namely competition for Fc receptors 
(19). Immune complexes that can inhibit 
ADCC are generated in mixtures of antibodies 
with lymphocytes (19). In kidney patients 
anti-HLA and anti-B cell antibodies, which 
are potent inhibitors of ADCC (10,18,20,23), 
are often present. The autologous blocking 
found in some of our transplant and dialysis 
patients may be because of the formation of 
immune complexes between antibodies and 
soluble antigens from transfusions or kidney 
grafts. 
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ELEVEN AND TWO-TInRDS YEARS' SURVIVAL AITER CANINE ORTHOTOPIC 
LNER TRANSPLANTATION' 
The first animal to survive chronically after 
orthotopic liver transplantation was a mongrel 
dog that received a hepatic homograft on March 
23, 1964. The recipient was estimated to be 2 
1 This work was supported by Research Projects 
MRIS 8118-01 and 7227-01 from the Veterans Ad-
ministration and by Grants AM-17260 and AM-0772 
from the National Institutes of Health. 
years old. The unrelated mongrel donor was of 
a different color and appearance. ImmunosUP-
pression was with azathioprine which was 
stopped after 120 days. Treatment was never 
resumed. The transplanted liver was bi0;?sied 
on several occasions during the next 5 :K~ars 
and was always thought to be normal (2,4). 
After a brief illness, the dog died on the night 
of December 8, 1975, at the estimated age of 14 
years and after a total survival post-transplan-
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tation of 11 years and 81/2 months. He had 
appeared to be well clinically until 1 or 2 days 
before death. 
Fo: most of the post-transplant period, the 
dog had normal liver function tests (Fig. 1). 
However, during the last 12 months of life, 
there was intermittent transaminasemia and 
elevation of the serum alkaline phosphatase. A 
few weeks before death, the serum bilirubin 
was increased to 2.5 mgllOO ml. 
At autopsy, the liver was of normal size. It 
weighed 2.7% of the body weight, which was 
12.5 kg. The liver had a nutmeg appearance 
and was hard. There were no abnormal venous 
coli", :rals suggestive of portal hypertension. 
The reconstructed vena cava above and below 
the liver and the portal vein were normal, with 
barely detectable sites of anastomosis. To arte-
rialize the liver, a segment of donor aorta in 
continuity with the hepatic artery had been 
anastomosed to the infrarenal recipient aorta. 
Although the hepatic artery was grossly nor-
mal, the homograft aorta had extensive calci-
fied atherosclerosis. 
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LIVER TRANSPLANT 
3-23-64 
... 
40 
ALKALINE PHOSPHATASE 30 
(Bodonsky Units) 20 
10 
Biliary reconstruction was with cholecysto-
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soft, variably colored green to 01 ange sludge. 
The stone analysis showed predominantly bili-
rubin with only trace amounts ;)f cholesterol 
and bile salts. 
Other significant findings at autopsy were 
pulmonary edema, coronary artery disease, 
and left ventricular hypertrophy. Th3 immedi-
ate cause of death was congestive heart failure. 
Histopathological evaluation of the homo-
graft revealed portal fibrosis and linking of the 
enlarged portal tracts to one another by connec-
tive tissue septa (Fig. 2). There was concentric 
scarring around the interlobular and septal bile 
ducts and proliferation of ductules at the mar-
gins of the portal tracts. Many of the larger bile 
ducts were dilated and filled with inspissated 
bile. The epithelium of the affected ducts was 
ulcerated and there were aggregates of small 
lymphocytes, plasma cells, and macrophages 
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FIGURE 2. Canine hepatic homograft at autopsy 11 years and 81/2 months after transplantation. Fibrous 
septa link enlarged portal tracts (arrows). There is proliferation of bile ductules and concentric scarring and 
mononuclear cell infiltration around the bile ducts. Hematoxylin and eosin, x 100. 
around the ducts. A few bile "thrombi" were 
present in the centrilobular part of the bile 
canaliculi. Liver cell damage was slight. The 
arteries and arterioles were normal. These 
changes are typical of chronic large duct biliary 
obstruction. There was no evidence of rejection. 
The thymus, mesenteric and mediastinal 
lymph nodes, and Peyer's patches appeared to 
be normal. The spleen had been removed at the 
time of transplantation. 
Examination of the rest of the tissues con-
firmed the narrowing of the coronary arteries 
by atherosclerosis, the hypertrophied left ven-
tricle, and the congestion and edema of the 
lungs. The atherosclerosis in the homograft 
aorta was severe, with large patches of calcifi-
cation and bone formation with marrow. By 
contrast the recipient aorta was normal. The 
kidneys were normal. 
Thus, although the dog died primarily of car-
diovascular manifestations of old age, a poten-
tially lethal biliary duct complication was pres-
ent which would have independently caused 
death within a short time. A partial obstruction 
of the cystic duct was apparently the main 
cause of the extensive stone and sludge forma-
tion that had affected both the extrahepatic and 
intrahepatic ducts. The intrahepatic biliary 
plugging with inspissated bile casts was similar 
to a syndrome that we (1,3) and Waldram et 
al. (5) have noted in humans. Such findings in 
animals and man point again to the recon-
structed biliary duct system as the Achilles' 
heel of liver transplantation. 
The completely normal findings in this dog's 
lymphoid system were of interest, since no im-
munosuppression whatever had been given for 
11112 years. 
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THE CELLULAR INFILTRATE IN CARDIAC ALLOGRAFT REJECTION IN MICE' 
There have been many studies of allograft 
rejection and the cellular response to this phe-
no"wnom (9, ~RI 16). The main cytological 
mal.ifestation of the allograft response is 
known to be the activation of lymphocytes and 
their transformation into blasts (4,20). A histo-
chemically active population of macrophages 
has also been demonstrated in the cellular infil-
trate that occurs as an immunological response 
to skin allografts in mice and it was thought 
that the high build-up of lysosomal activity in 
these cells could be responsible for rejection 
(18). 
11 was originally thought that the humoral 
antibody response to an allograft was very 
much delayed, reaching its peak after destruc-
tion of the graft. This was cited as part of the 
evidence that humoral factors do not play a 
significant role in the rejection process. How-
ever, antibodies are demonstrable in the serum 
soon after grafting from the 4th day onward 
and have been shown to reach their maximum 
titer at about the same time the graft destruc-
tiol' 'c complete (2). The classic expenments of 
Algire and his colleagues () indicate that hu-
moral antibodies alone probably do not play an 
important role in solid allograft destruction, 
despite the fact that such hosts produce fairly 
high titers of specific H-2 antibodies. It would 
seem that, although destruction of solid tissue 
allografts is primarily mediated by immunolog-
ically competent cells, humoral factors may 
play an ancillary role. The evidence incriminat-
ing 1;:: moral factors as major contributors to the 
de~:l uction of solid tissue allografts remains 
unsatisfactory, and the current view is that, as 
far as the majority of types of solid tissue allo-
grafts are concerned, destruction is mediated 
by a cellular rather than a humoral immunity. 
Since the initial observations that the thy-
mUs-dependent (T) line of lymphocytes was 
I Supported in part by Grants HL 13108-06 and 
d~!·MOOPS-MO from the National Institutes of Health. 
necessary for graft rejection (17), several T cell 
as well as non-T cell candidates for effector cells 
in cell-mediated immunity have been proposed. 
Antibody-dependent cell-mediated lysis of tar-
get cells in vitro may be carried out by a subset 
of B cells and/or surface adherent cells belong-
ing to the monocyte-Macrophage-reticulum cell 
line (5, 6, 7,19,22). In terms of in vivo graft 
rejection, however, it is likely that the effector 
cell population must come into contact with 
graft tissue and therefore be represented in the 
immune cellular infiltrate. Since it is now pos-
sible to identify lymphocytes in frozen tissue 
sections which bear surface antigens character-
istic of the T cell and B cell (Ig bearing) lines 
(8,10-13), we initiated a series of experiments 
to identify the cells involved in the immune 
cell infiltrates to cardiac allografts in mice. 
The purpose of this study is 3-fold: to attempt 
to establish the type of cells present in the 
graft-host rejection site, the time relationships 
of the appearance of these cells, and fmally to 
fmd out whether the type of cell changes as the 
graft becomes established. 
Mice 
Three groups of mice were used. 
A. Allogeneic group. Donor hearts were 
from newly born (12 to 24 hr) BALB/cJ mice. 
The recipients were healthy adult C57BL/6J 
mice. 
B. Preimmunized group. This group was 
similar to group A except that adult C57BL/6J 
recipients were preimmunized wiih 1 x 107 
washed BALB/cJ spleen cells injected i. p. 10 
days prior to transplant. 
C. Syngeneic group. Both the newly born 
donor hearts and the recipient adult mice were 
of the BALB/cJ strain. 
Antisera 
A. Anti-T. Rabbit anti-BALB thymus serum 
was prepared as previously described () 2). This 
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